FTC sues major pharmacy reward managers about insulin costs The agency introduced motion versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing cost of lifestyle-saving insulin prescription drugs. The offer have to be finished by Sept. 30 or potential buyers can https://ayahealthcareaddress97407.goabroadblog.com/30008523/new-step-by-step-map-for-healthcare-news